About Raphael Wisniewski
Form D filings for Bioventrix in 2023 list Raphael Wisniewski as director.
Raphael Wisniewski reports to the SEC as a director or major shareholder of 2 public companies: Axonics (AXNX) and Tobira Therapeutics (TBRA).
Raphael Wisniewski first appears on SEC filings in 2013.
Experience
This experience comes from SEC filings. The years are when the filings name Raphael Wisniewski in the role, so the role may have started earlier or lasted longer.
Bioventrix, Inc.
Director
2023 · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
AI
Axonics, Inc.
Director and 10% owner
2018 – 2020 · Public company (AXNX)
TI
Tobira Therapeutics, Inc.
Director and 10% owner
2013 – 2014 · Public company (TBRA)
Key Colleagues at Startups
The people Raphael Wisniewski works with at each company, as listed on that company's latest Form D.
Bioventrix, Inc. · Form D, Apr 4, 2023
RC
Raymond Cohen
Director
Steve Chartier
Executive officer
JD
James Dillon
Executive officer and director
David Richmond
Co-Chief Executive Officer and director
AH
Andrew Hinson
Director
AC
Andrew Coats
Director
BC
Bihua Chen
Director
MT
Michael Taglich
Director
RS
Rinda Sama
Director
OY
Ori Ben-Yehuda
Executive officer
WA
William Abbott
Chief Financial Officer
CW
Christopher Wolff
Executive officer